@article{f07176c3b17949fbbdf222e7f869ffa8,
title = "Magnetic resonance imaging proton density fat fraction as an imaging-based biomarker of treatment response in patients with nonalcoholic steatohepatitis",
author = "Stine, \{Jonathan G.\} and Rohit Loomba",
note = "Funding Information: This study was supported by National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health grant K23DK13190 (to J.G.S.). R.L. receives funding support from NCATS (grant 5UL1TR001442); National Institute of Diabetes and Digestive and Kidney Diseases (grants U01DK061734, U01DK130190, R01DK106419, R01DK121378, R01DK124318, and P30DK120515); National Heart, Lung, and Blood Institute (grant P01HL147835); and National Institute on Alcohol Abuse and Alcoholism (grant U01AA029019). Nonalcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease worldwide for which there remains no regulatory agency–approved drug therapy or cure. NAFLD encompasses a spectrum of histological features, including nonalcoholic fatty liver, nonalcoholic steatohepatitis (NASH), and cirrhosis. Invasive liver biopsy remains the gold standard for diagnosis and monitoring of treatment response in patients with NASH. Funding Information: This study was supported by National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health grant K23DK13190 (to J.G.S.). R.L. receives funding support from NCATS (grant 5UL1TR001442); National Institute of Diabetes and Digestive and Kidney Diseases (grants U01DK061734, U01DK130190, R01DK106419, R01DK121378, R01DK124318, and P30DK120515); National Heart, Lung, and Blood Institute (grant P01HL147835); and National Institute on Alcohol Abuse and Alcoholism (grant U01AA029019). ",
year = "2022",
month = dec,
doi = "10.1002/cld.1249",
language = "English (US)",
volume = "20",
pages = "198--201",
journal = "Clinical Liver Disease",
issn = "2046-2484",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "6",
}